Streetbeat News

Stock Prices

NUWE

Nuwellis, Inc. (NASDAQ:NUWE) announced new real-world data showing positive responses in pediatric patients with fluid overload to its Aquadex ultrafiltration therapy with continuous hematocrit monitoring. The study, published in Pediatric Nephrology, demonstrated successful treatment without complications. The therapy is FDA-cleared for use in adults and pediatric patients weighing 20 kg or more. Nuwellis emphasizes the importance of managing fluid overload, which is linked to increased mortality in pediatric patients.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:09 pm

AGFY

Agrify Corporation (NASDAQ:AGFY) reported Q1 earnings with a loss of $9.63 per share, surpassing the estimated loss of $20.20 per share. However, the company's sales of $5.80 million fell short of the $14.05 million estimate, marking a significant decrease from the $26.02 million in sales reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:08 pm

ASST

CUEN

DRCT

GDC

GDEV

HRYU

LQR

LVO

MOBQ

NFTG

STBX

In Tuesday's pre-market session, several communication services stocks experienced significant movements. GDEV, STBX, HRYU, LVO, and CUEN were among the gainers, with increases ranging from 5.1% to 9.5%. Conversely, MOBQ, ASST, GDC, LQR, NFTG, and DRCT were the losers, with declines between 3.82% and 13.4%. These movements reflect changes in investor sentiment and could impact the market value of these companies' shares.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 1:06 pm

EIGR

HSCS

ICAD

RDHL

RNA

THAR

In Tuesday's pre-market session, several healthcare stocks experienced significant movements. Avidity Biosciences (RNA) led the gainers with a 38.1% increase, while Tharimmune (THAR) saw the largest drop among the losers, falling 69.5%. Other notable movers included Heart Test Laboratories (HSCS), Redhill Biopharma (RDHL), icad (ICAD), and Eiger BioPharmaceuticals (EIGR) with substantial gains, and SenesTech (SNES), CohBar (CWBR), Nexalin Technology (NXL), Better Therapeutics (BTTX), and Altamira Therapeutics (CYTO) with notable losses.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 1:06 pm

BGLC

BLDE

ESGL

HYFM

IPDN

PMEC

SATL

SCWO

SHIM

SIDU

WLGS

XOS

In Tuesday's pre-market session, several industrial stocks experienced significant movements. ESGL Holdings led the gainers with a 58.7% increase to $1.42, while BioNexus Gene Lab saw the largest decline among the losers, dropping 21.1% to $0.55. Other notable gainers include Sidus Space, 374Water, Primech Holdings, Shimmick, and Professional Diversity. On the losing side, Hydrofarm Holdings Group, Xos, WANG & LEE Group, Satellogic, and Blade Air Mobility also saw their stock prices fall.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 1:06 pm

AEVA

SMX

STIX

SVRE

In Tuesday's pre-market session, several IT stocks showed significant movement. SMX, SVRE, AEVA, VERB, CYN, and AUUD were gainers, with SMX leading at a 39.7% increase. Losers included STIX, WTO, ZS, INSG, CISO, and KOPN, with STIX dropping 9.3%. Zscaler's stock fell after Q1 earnings were released.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 1:06 pm

DMK

DMK Pharmaceuticals has regained full rights to SYMJEPI from U.S. WorldMeds and is now looking for out-license opportunities for the product both in the US and internationally. The company's focus is on maximizing shareholder value through these efforts.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:06 pm

ICCM

IceCure Medical announced the publication of a study in 'Cancers' showing the safety and efficacy of its ProSense system. The study reported a 92% disease-free survival rate at a median follow-up of 26.5 months.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:06 pm

SEEL

Seelos Therapeutics, Inc. (SEEL) shares are set to resume trading at 9:00 a.m. ET after a halt.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:03 pm

YOSH

Yoshiharu Global Co., which may be referred to by its ticker symbol YOSH, is set to resume trading at 9:00 a.m. ET after a trading halt.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:03 pm